(Q53267588)

12 May 2018

title

Can 18-FDG-PET during radiotherapy replace post-therapy scanning for detection/demonstration of tumor response in head-and-neck cancer? (English)

1 reference

12 May 2018

Can 18-FDG-PET During Radiotherapy Replace Post-Therapy Scanning for Detection/Demonstration of Tumor Response in Head-and-Neck Cancer? (English)

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

adaptive radiation therapy

29 July 2024

main subject

0 references

fludeoxyglucose (18F)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20932677

Fluorodeoxyglucose Positron Emission Tomography

29 July 2024

1 reference

5

Guy Storme

1 reference

12 May 2018

author name string

Gaëtane Ceulemans

1

1 reference

12 May 2018

Mia Voordeckers

2

1 reference

12 May 2018

Ashraf Farrag

3

1 reference

12 May 2018

Douwe Verdries

4

1 reference

12 May 2018

Hendrik Everaert

6

1 reference

12 May 2018

language of work or name

English

0 references

publication date

6 October 2010

1 reference

12 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0360301610009508?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

https://api.elsevier.com/content/article/PII:S0360301610009508?httpAccept=text/plain

29 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

International Journal of Radiation Oncology Biology Physics

29 July 2024

published in

1 reference

12 May 2018

volume

81

1 reference

12 May 2018

issue

4

1 reference

12 May 2018

page(s)

938-942

1 reference

12 May 2018

Early assessment of clinical response to concurrent chemoradiotherapy in head and neck carcinoma using fluoro-2-deoxy-d-glucose positron emission tomography.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

29 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation.

29 July 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.

29 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

PET monitoring of therapy response in head and neck squamous cell carcinoma

29 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

29 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma.

29 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).

29 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

18-F-fluorodeoxyglucose-positron emission tomography evaluation of early metabolic response during radiation therapy for cervical cancer

29 July 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

29 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Positron emission tomography in the early follow-up of advanced head and neck cancer.

29 July 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET.

29 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation

29 July 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy?

29 July 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Positron-emission tomography (PET) and PET/CT in head and neck cancer - recommendations of an interdisciplinary consensus conference

29 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Current status of FDG-PET for head and neck cancer

29 July 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study

29 July 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Longitudinal assessment of parotid function in patients receiving tomotherapy for head-and-neck cancer

29 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience

29 July 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Interactions between outcomes and tumor response to preoperative cisplatin-sensitized radiotherapy in advanced head and neck cancer. Southern New Jersey Head and Neck Cancer Treatment Group

29 July 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcome.

29 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma

29 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

Diagnostic and prognostic value of [(18)F]fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma.

29 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.IJROBP.2010.07.019

29 July 2024

Identifiers

1 reference

12 May 2018

1 reference

12 May 2018